212.249.9955 Menu
Dr. David Rapaport | Top Plastic Surgeon NYC

David P. Rapaport M.D., F.A.C.S.

Board Certified New York Plastic Surgeon, David. P. Rapaport, son of holocaust survivors, began the study of medicine at Boston University six-year medical program at age 16 before transferring to Israel’s Tel Aviv University, where he earned his medical degree. He trained in general surgery at Boston’s Beth Israel Hospital, a major teaching hospital of Harvard Medical School, where he served as Chief Resident. He then did his plastic surgery training at the New York University’s Institute of Reconstructive Plastic Surgery, which is widely regarded as the nation’s top plastic and cosmetic surgery residency program. There too, he was appointed Executive Chief Resident. After a one-year microsurgery fellowship, Dr. Rapaport moved to Florida, where from 1993 to 1997, he was a key faculty member at the University of South Florida. There, he developed a successful and respected practice as a cosmetic plastic surgeon. During his four years in Florida, he also helped craft legislation requiring broader insurance coverage for reconstructive breast surgery, directed the cosmetic surgery education of residents, and did pioneering work in endoscopic and minimal incision breast and oncologic (melanoma) surgery. In 1997, he returned to New York City and opened his private cosmetic surgery practice in Manhattan, New York.

Dr. Rapaport specializes in New York Breast Augmentation, Liposuction, and Coolsculpting. All of Dr. Rapaport’s procedures are performed on-site in his fully accredited office surgical suite on Fifth Avenue in Manhattan, New York. Dr. Rapaport also offers cosmetic and non-surgical procedures such as injectable fillers, Botox, earlobe repair, mole removal, and more. Many of these procedures require no down-time.


Held: 1985-1990 Resident, Plastic Surgery

  • Chief Resident
  • Harvard Medical School Clinical Fellow
  • Beth Israel Hospital
  • Boston, Massachusetts

1990-1992 Resident, Plastic Surgery

  • Chief Resident, Plastic Surgery
  • Institute of Reconstructive Plastic Surgery
  • New York University Medical Center
  • New York, New York

1992-1993 Fellowship, Microsurgery

  • Institute of Reconstructive Plastic Surgery
  • New York University Medical Center
  • New York, New York

1993-1997 Assistant Professor

  • Division of Plastic and Reconstructive Surgery
  • University of South Florida College of Medicine

1998-Present Private Practice

  • New York, New York


Boston University

Six – Year Medical Program

Boston, Massachusetts

Tel Aviv University

School of Medicine

Ramat Aviv, Israel

Doctor of Medicine

Boards, Societies, and Honors

  • Board Certified, American Board of Surgery
  • American Society for Aesthetic Plastic Surgery
  • Board Certified, American Board of Plastic Surgery
  • Built and directed the USF Residents’ Cosmetic Surgery Clinic
  • Fellow, American College of Surgeons
  • Plastic Surgery Research Council
  • National faculty and Original Co-developer with Ethicon Corporation: Endoscopically Assisted Saphenous Vein Harvest
  • National Faculty for Advanced Injection Techniques of Sculptra ™ (poly L-latic acid) 2006
  • American Society of Plastic and Reconstructive Surgeons

Research History

Sentinel lymphadenectomy techniques:

Work with Lockhead Martin and Neoprobe Corporation to develop improved (miniaturized) gamma detectors for sentinel node biopsy. Co-Director of training sessions on sentinel lymphadenectomy techniques. Courses given several times each year (since 1995) are attended by U.S. and international surgeons.

Minimal Incision Subcutaneous Surgery:

Development of and instruction in technique for endoscopically harvesting the saphenous vein for coronary artery bypass graft (CABG) surgery. Principal Investigator in prospective study comparing open versus closed saphenous harvest techniques. Developed new minimal incision technique for groin dissection in malignant melanoma. Original technique published in Balch’s Cutaneous Melanoma, see Chapters below. Development of a model for fat necrosis in the Zucker (fat) rat.


  • Dr. David Rapaport | Top Plastic Surgeon NYC
  • Dr. David Rapaport | Top Plastic Surgeon NYC
  • Dr. David Rapaport | Top Plastic Surgeon NYC
  • Dr. David Rapaport | Top Plastic Surgeon NYC
  • Dr. David Rapaport | Top Plastic Surgeon NYC
  • Dr. David Rapaport | Top Plastic Surgeon NYC


Stadelmann W, Rapapot DP, Reintgen DS. Prognostic factors in melanoma.

Balch, Cutaneous Melanoma: 3rd edition, 1998.

Rapaport DP, Stadelmann W, Reintgen DS. Groin dissection.

Balch, Cutaneous Melanoma: 3rd edition, 1998.


Selected Publications

Ziv P. Rapaport DP, Dinstman M: Primary hyperparathyroidism associated with panctyosis. New England Journal of Medicine 313(3), 187, 1985.

Rapaport DP, Ziv Y, Rubin M, Huminer D, Dinstman M: Primary hyperthyroidism in children. Journal of Pediatric Surgery 21 (5); 395-397, 1986.

Rapaport DP, Breitbart AS, Karp NS, Siebert JW: Successful microvascular replantation of a completely amputated ear. Microsurgery 14; 312-314, 1993.

Mogilner A, Grossman JAI, Ribary U, Joliot M, Volkmann J, Rapaport DP, Beasley RW, Llinas RR: Somatosensory cortical plasticity in adult humans revealed by magnetoencephalography. Proceedings National Academy of Science 90: 3593-3597, 1993.

Wang X, Heller R, Cruse CW, VanVoorhis N, Glass F, Fenske N, Berman C, Leo-Messina J, Rapaport D, Wells K, DeConti R, Moscinski L, Stankard C, Puleo C, Reintgen D. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 220; 769-774, 1994.

Reintgen D, Albertini F, Miliotes SB, Berman C, Cruse CW, Fenske N, Glass F, Puleo C, Wang X, Wells KE, Rapaport DP, DeConti R, Messina J, Heller R: The accurate staging and modern day treatment of malignant melanoma. Can Res, Therapy and Control 4; 183-197, 1995.

Rapaport DP, Bass LS, Aston SJ: Influence of steroids on post-operative swelling after facioplasty: A prospective randomized study. Plastic Reconstructive Surgery 96 (7); 1547-1552, 1995.

Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, Fenske NA, Gilbert RA, Mir LM, Reintgen DS. Phase I/II Trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Canc 77 (5); 964-971, 1996.

Albertini JJ, Cruse CW, Rapaport DP, Wells K, Ross M, DeConti R, Bermann CG, Jared K, Messina J, Lyman G, Glss F, Fenske N, Reintgen DS. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 223 (2); 217-224, 1996.

Rapaport DP, Stadelmann WK, Greenwald DP. Incidence and natural history of saline-filled breast implant deflations: Comparison of blunt-tipped versus cutting and tapered needles. Plastic Reconstructive Surgery 100: 1028-1032, 1997.

Stadelmann WK, Rapaport DP, Payne W, Shons AR, Krizek TK. Residency training in aesthetic surgery: maximizing the residents’ experience. Plastic Reconstructive Surgery 101;1973-1977, 1998.

Wells, K.E., Stadelmann, W.K., Rapaport, D.P., Hamlin, R., Cruse CW, Reintgen DS: Parotid Selective Lymphadenectomy in Malignant Melanoma, Annals of Plastic Surgery, 1999;43:1-6.


Selected Presentations

Payne W, Curse CW, Rapaport D, Wells K, Daniels S, Reintgen DS. Selective lymphadenectomy: Sentinel node biopsy in head and neck melanoma, Amer Soc of Plast and Recon Surg, 1994.

Albertini J, Milliotes G, Cruse CW, DeConti R, Rapaport D, Berman C, Glass F, Fenske N, Reintgen DS. Quality and cost outcome measurement in melanoma surgical care. Soc of Surg Oncol, Boston, 1994.

Wells K, Cruse CW, Rapaport DP, Payne W, Petsoglou C, Reintgen DS, Sentinel lymph node biopsy in melanoma of the head and neck. Amer Soc of Plast and Recon Surg, 1995.

Rapaport DP, Albertini J, Cruse CW, et, Al.: Identification of the sentinel node in melanoma patients using radiolymphoscintigraphy and vital blue dye. 18th Ann Sem of Canc Res in FL, Amer Canc Soc, FL Div, Orlando, Mar 1995.

Albertini J, Cruse CW, Rapaport DP, Wells K, DeConti R, Lyman G, Glass F, Messina J, Berman C, Jared K, Reintgen D. Identification of the sentinel node in melanoma patients using radiolymphoscintigraphy and vital blue dye injection. Amer Soc of Plast and Recon Surg, 1995.

Rapaport DP, Stadelmann W. Malignant melanoma: Advances in evaluation and treatment. ASPRS 65th An Sci Mtg. Dallas, TX., 1996.

Rapaport DP, Stadelmann W. Malignant melanoma: Advances in evaluation and treatment. ASPRS 66th An Sci Mtg. San Francisco, CA., 1997.

Rapaport DP, Stadelmann W. Malignant melanoma: Advances in evaluation and treatment. ASPRS 67th An Sci Mtg. Boston, MA., 1998.

Rapaport DP, Stadelmann W. Malignant melanoma: Advances in evaluation and treatment. ASPRS 68th An Sci Mtg. New Orleans, LA., 1999.

Schedule a Consultation



Schedule a Consultation

By submitting this consultation form you consent to be contacted via phone/text or email.


View Update Virtual Consult In-Office Consult


We are excited to announce that as of June 8th, 2020, our office will be open for ALL appointment types including Surgery, Cosmetic Injectables, Earlobe Repairs, Mole Removals, CoolSculpting, CoolTone, Morpheus8, miraDry, Skincare services, and more!

During this time, we are still encouraging virtual consultations & follows up as an initial step prior to an in-person appointment. We are requesting that established patients virtually consult/review their treatment plans with Dr. Rapaport or a medical aesthetician in advance of their scheduled treatments/procedures. We will be providing you with specific procedure-related instructions prior upon scheduling. If you left a deposit for a treatment and have not yet been contacted by our staff, please call, or e-mail our office so that we may get you scheduled.

Dr. Rapaport & his team have been working diligently to get our office prepared for our re-opening. Our main priority is the health and safety of our patients and staff. Thank you for following our guidelines and being so patient. See below for our re-opening guidelines:

  1. Please take the time to thoroughly read and complete our updated Appointment Policies, COVID-19 Patient Protocols, ASAPS COVID-19 Consent, and COVID-19 Patient Screening Questions. These forms will be sent via email and must be completed prior to your appointment. This will help to screen patients and ensure social distancing in the office.
  2. When we contact you, please let us know if you are or have been sick in the last 3 weeks, have been in close or prolonged contact with anyone who has been sick during that time, or have travelled outside the United States, or have returned from the following states within the last 14 days that have been added to the high covid risk government list including Alabama, Arizona, Arkansas, Florida, North Carolina, South Carolina, Texas, and Utah. Specific symptoms of COVID-19 may include fever, cough, loss of sense of smell and taste, chest pressure, or shortness of breath
  3. Alert us if you have any other health problems that make you more susceptible to developing COVID-19 or are at increased risk. Although our office has implemented additional measures to keep you safe during this time, we encourage you to consult your primary care physician for further instructions on how to remain safe. Typically, patients over age 65 who also have respiratory ailments, heart disease, hypertension, diabetes, or are immunocompromised are at greater risk.
  4. Medication refill and product requests: Routine requests for medication refills must be requested electronically through your pharmacy. Should you need to purchase skin or haircare products and would like them mailed to you, please e-mail office@DrRapaport.com or phone us at 212-249-9955.
  5. We ask that you come alone to office visits, if possible. To limit exposure and practice social distancing, we are doing our best to minimize the number of people in the office at one time. If you require someone to accompany you to your visit, he/she will need to be with you at all times throughout the duration of your appointment or they will be asked to wait outside.
  6. Please make sure to bring a mask with you to your office visit. If you do not have a mask, we will provide one for you. 
  7. Please abstain from handshake greetings and keep a “social distance” of 6 feet or more from other individuals when in the office whenever possible. 
  8. As soon as you enter the office you will be asked to use hand sanitizer provided to you upon arrival and departure from the practice. Coat both the front and back of your hands and wrists and let them air dry. Wash your hands often with soap and water for at least 20 seconds and avoid touching your face.  
  9. Please reply to all email and texts that we send you. We are working with limited personnel and resources, so responding to these messages will enable us to keep in touch with you safely. 
  10. We will provide ongoing care remotely using telemedicine. Our telemedicine system will allow us to speak with you, evaluate your face/body/breasts, prescribe treatment, and/or give you advice. We will be contacting you about your existing appointment to determine whether a virtual or in-person appointment is best. 
  11. You can obtain good and reliable information about local conditions regarding the pandemic at https://coronavirus.health.ny.gov/home

For any questions and/or concerns, please call our office at 212-249-9955 or email us at office@DrRapaport.com. We know each of you are eager to get back to your treatment regimens, so we will be extending our hours to accommodate everyone as best we can while maintaining health & safety protocols!

We thank you for your continued support & confidence in Dr. Rapaport and our staff the past few months. We look forward to welcoming you back to our office!

Virtual Consultation